# Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/erlotinib-as-second-line-treatment-in-patients-with-advanced-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yi‐Long Wu,Caicun Zhou,Ying Cheng,Shun Lü,G.-Y. Chen,Cheng Huang,Yulu Huang,Hong‐Hong Yan,Shengxiang Ren,Yao-Bin Liu,Jin‐Ji Yang |
| Citations | 241 |
| DOI | 10.1093/annonc/mds529 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.annalsofoncology.org/article/S0923753419371753/pdf |
| OpenAlex ID | https://openalex.org/W2153979476 |
| PMID | 23129122 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Hong‐Hong Yan](https://scholariq.org/researchers/hong-hong-yan/)
- [Jin‐Ji Yang](https://scholariq.org/researchers/jin-ji-yang/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.